Terrie Curran
Chief Executive Officer at PHATHOM PHARMACEUTICALS, INC.
Net worth: 1 M $ as of 2024-05-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Frank Karbe | M | 55 | 8 years | |
David Socks | M | 49 | 6 years | |
James Topper | M | 62 | 6 years | |
Bhaskar Chaudhuri | M | 69 | 8 years | |
Kathleen Sebelius | F | 75 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 6 years |
David Elkins | M | 55 | 6 years | |
Mark Guinan | M | 62 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 6 years |
Todd Watanabe | M | 56 | 8 years | |
Eric Venker | M | 37 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 7 years |
Michael Cola | M | 64 | 5 years | |
Patrick Heron | M | 53 | 8 years | |
Asit Parikh | M | 52 | 5 years | |
Sue-Jean Lin | F | 65 | 3 years | |
Mark Stenhouse | M | 57 | 4 years | |
Chirfi Guindo | M | 58 | 13 years | |
Lene Skole-Sørensen | F | 65 | 9 years | |
Matthew Gline | M | 40 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 8 years |
Azmi Nabulsi | M | 64 | 6 years | |
Masaru Matsuda | M | 53 | 2 years | |
Jay Ramsinghani | M | - | 4 years | |
Neha Krishnamohan | F | 37 | 2 years | |
Dalton Smart | M | 58 | 15 years | |
Howard Welgus | M | 72 | 8 years | |
Heidi Fields | F | 69 | 5 years | |
David C. Marek | M | 59 | 3 years | |
Molly Henderson | F | 54 | 2 years | |
Jeremy Levin | M | 70 | 7 years | |
Halley Gilbert | F | 54 | 4 years | |
Keith Manchester | M | 55 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 10 years |
Adele Gulfo | F | 61 | 5 years | |
Ayisha Jeter | F | - | 4 years | |
Frank Torti | M | 45 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 6 years |
Keith Leonard | M | 62 | 3 years | |
Lars Erik Holmqvist | M | 64 | 9 years | |
Charlotte Merritt | F | 61 | 7 years | |
Eric Sciorilli | M | - | - | |
Zachary Carpenter | M | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 5 years |
Clarence Machado | M | 60 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
Jessica Robison | F | - | 5 years | |
Richard Pulik | M | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 3 years |
Nikhil Kehtarpal | M | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 5 years |
George Bickerstaff | M | 68 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
Gillian Cannon | M | 60 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 4 years |
Ann Li Lee | M | 63 | 6 years | |
Andrew Fromkin | M | 58 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 3 years |
Nick Benedetto | M | - | - | |
David Berk | M | 45 | 5 years | |
Meg Elias | F | 58 | 5 years | |
Sef P. Kurstjens | M | 60 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
Tom Harris | M | - | - | |
Don Plummer | M | - | - | |
Sakshi Chhabra | F | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
Paul Davis | M | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 8 years |
Kenneth Ludlum | M | 70 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
Patrick Burnett | M | 52 | 4 years | |
Ilan Oren | M | 40 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
Berndt A. E. Modig | M | 65 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
Rakhi Kumar | F | 44 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 9 years |
Pierre Legault | M | 63 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
Timothy Nelson | M | 60 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Fred Hassan | M | 78 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | 6 years |
Jacqualyn Fouse | M | 62 | 7 years | |
Robert Hugin | M | 69 | 19 years | |
Aditya Kohli | M | 36 | 2 years | |
Timothy J. Smith | M | - | - | |
Richard Clark | M | 77 | 6 years | |
Scott Smith | M | 61 | 10 years | |
Peter Kellogg | M | 67 | 5 years | |
Tadataka Yamada | M | 78 | 3 years | |
Sven Håkan Björklund | M | 68 | 5 years | |
Thomas Daniel | M | 70 | 10 years | |
Matthew Lang | M | 47 | - | |
Lynn Seely | M | 65 | 5 years | |
Todd Branning | M | 54 | 1 years | |
Joe Hand | M | - | 6 years | |
Scott Burrows | M | 47 | 4 years | |
Jean-Marie Canan | M | 68 | 5 years | |
Brendan Delaney | M | 49 | 6 years | |
Julia Haller | M | 69 | - | |
Michael Nally | M | 48 | 10 years | |
Andreas Eggert | M | 56 | 5 years | |
Thomas Sabatino | M | 65 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | 5 years |
Melanie Lee | M | 65 | 3 years | |
Jens Jesper Ovesen | M | 67 | 3 years | |
C. Nicholson | M | 69 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | 4 years |
Perry Karsen | M | 69 | 3 years | |
Susan Ellen Wolf | F | 69 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | 5 years |
Michael Bonney | M | 65 | 4 years | |
Thomas Shenk | M | 77 | 11 years | |
William Rastetter | M | 75 | 6 years | |
Gilla Kaplan | M | 76 | 20 years | |
Richard Morgan | M | 79 | 29 years | |
John Weiland | M | 68 | 1 years | |
Patricia Hemingway Hall | F | 71 | 1 years | |
Ulf Arne Wiinberg | M | 66 | 6 years | |
Lawrence V. Stein | M | 74 | 3 years | |
Robert Hershberg | M | 61 | 6 years | |
Corey Padovano | M | - | 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 86 | 87.76% |
United Kingdom | 9 | 9.18% |
Denmark | 8 | 8.16% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Terrie Curran
- Personal Network